105 related articles for article (PubMed ID: 18021193)
1. CD98 immunoreactivity in multinucleated giant cells of glioblastomas: an immunohistochemical double labeling study.
Takeuchi H; Kubota T; Kitai R; Nakagawa T; Hashimoto N
Neuropathology; 2008 Apr; 28(2):127-31. PubMed ID: 18021193
[TBL] [Abstract][Full Text] [Related]
2. Mitotic activity of multinucleated giant cells with glial fibrillary acidic protein immunoreactivity in glioblastomas: an immunohistochemical double labeling study.
Takeuchi H; Sato K; Ido K; Kubota T
J Neurooncol; 2006 May; 78(1):15-8. PubMed ID: 16718521
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules.
Ohgimoto S; Tabata N; Suga S; Nishio M; Ohta H; Tsurudome M; Komada H; Kawano M; Watanabe N; Ito Y
J Immunol; 1995 Oct; 155(7):3585-92. PubMed ID: 7561057
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.
Samaras V; Stamatelli A; Samaras E; Arnaoutoglou C; Arnaoutoglou M; Stergiou I; Konstantopoulou P; Varsos V; Karameris A; Barbatis C
Pathol Res Pract; 2009; 205(11):765-73. PubMed ID: 19616898
[TBL] [Abstract][Full Text] [Related]
5. A clinico-immunohistochemical study of giant cell glioblastoma.
Huang MC; Kubo O; Tajika Y; Takakura K
Noshuyo Byori; 1996 Apr; 13(1):11-6. PubMed ID: 8916121
[TBL] [Abstract][Full Text] [Related]
6. Suppression of FRP-1/CD98-mediated multinucleated giant cell and osteoclast formation by an anti-FRP-1/CD98 mAb, HBJ 127, that inhibits c-src expression.
Tajima M; Higuchi S; Higuchi Y; Miyamoto N; Uchida A; Ito M; Nishio M; Komada H; Kawano M; Kusagawa S; Tsurudome M; Ito Y
Cell Immunol; 1999 May; 193(2):162-9. PubMed ID: 10222058
[TBL] [Abstract][Full Text] [Related]
7. Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time.
Nafe R; Franz K; Schlote W; Schneider B
Clin Neuropathol; 2003; 22(3):129-36. PubMed ID: 12809355
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-rich multinucleated giant cells in the colon: a case report with transmission electron microscopy, immunohistochemistry, and in situ hybridization.
Lewin-Smith M; Wahl SM; Orenstein JM
Mod Pathol; 1999 Jan; 12(1):75-81. PubMed ID: 9950166
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of giant cell in glioblastoma.
Kawano H; Kubota T; Sato K; Goya T; Arikawa S; Wakisaka S
Clin Neuropathol; 1995; 14(2):118-23. PubMed ID: 7606897
[TBL] [Abstract][Full Text] [Related]
10. PCNA and Ki-67 immunoreactivity in multinucleated cells of giant cell fibroma and peripheral giant cell granuloma.
Mighell AJ; Robinson PA; Hume WJ
J Oral Pathol Med; 1996 May; 25(5):193-9. PubMed ID: 8835814
[TBL] [Abstract][Full Text] [Related]
11. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.
Hsu CY; Ho DM; Yang CF; Chiang H
Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460
[TBL] [Abstract][Full Text] [Related]
12. Function of fusion regulatory proteins (FRPs) in immune cells and virus-infected cells.
Tsurudome M; Ito Y
Crit Rev Immunol; 2000; 20(3):167-96. PubMed ID: 10968370
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma multiforme in three baboons (Papio spp).
Porter BF; Summers BA; Leland MM; Hubbard GB
Vet Pathol; 2004 Jul; 41(4):424-8. PubMed ID: 15232146
[TBL] [Abstract][Full Text] [Related]
14. Expression of proinflammatory cytokines and its relationship with virus infection in the brain of macaques inoculated with macrophage-tropic simian immunodeficiency virus.
Xing HQ; Moritoyo T; Mori K; Sugimoto C; Ono F; Izumo S
Neuropathology; 2009 Feb; 29(1):13-9. PubMed ID: 18507770
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human immunodeficiency virus gp160-mediated cell fusion by antibodies against fusion regulatory protein 1.
Ohgimoto S; Tabata N; Suga S; Tsurudome M; Kawano M; Nishio M; Okamoto K; Komada H; Watanabe N; Ito Y
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2747-56. PubMed ID: 8922468
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of c-Met expression in glioblastomas.
Kong DS; Song SY; Kim DH; Joo KM; Yoo JS; Koh JS; Dong SM; Suh YL; Lee JI; Park K; Kim JH; Nam DH
Cancer; 2009 Jan; 115(1):140-8. PubMed ID: 18973197
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
19. Aurora-B dysfunction of multinucleated giant cells in glioma detected by site-specific phosphorylated antibodies.
Fujita M; Mizuno M; Nagasaka T; Wakabayashi T; Maeda K; Ishii D; Arima T; Kawajiri A; Inagaki M; Yoshida J
J Neurosurg; 2004 Dec; 101(6):1012-7. PubMed ID: 15597762
[TBL] [Abstract][Full Text] [Related]
20. Minichromosome maintenance protein 7: a reliable tool for glioblastoma proliferation index.
Facoetti A; Ranza E; Benericetti E; Ceroni M; Tedeschi F; Nano R
Anticancer Res; 2006; 26(2A):1071-5. PubMed ID: 16619508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
